Outcome of Immune Checkpoint Inhibitor and Molecular Target Agent Combination for Advanced Hepatocellular Carcinoma: Beyond Sorafenib Era

Outcome of Immune Checkpoint Inhibitor and Molecular Target Agent Combination for Advanced Hepatocellular Carcinoma: Beyond Sorafenib Era

Bibliographic Details
Main Author:	Nae-Yun Heo
Format:	Article
Language:	English
Published:	Jin Publishing & Printing Co. 2021-03-01
Series:	The Korean Journal of Gastroenterology
Online Access:	http://www.kjg.or.kr/journal/view.html?uid=5686&vmd=Full

Similar Items

Genetic Heterogeneity, Therapeutic Hurdle Confronting Sorafenib and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
by: Sara M. Atwa, et al.
Published: (2021-08-01)

Beyond First-Line Immune Checkpoint Inhibitor Therapy in Patients With Hepatocellular Carcinoma
by: Rohini Sharma, et al.
Published: (2021-03-01)

Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment
by: Ze-Long Liu, et al.
Published: (2021-05-01)

Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
by: Ziyu Liu, et al.
Published: (2019-11-01)

Response Prediction in Immune Checkpoint Inhibitor Immunotherapy for Advanced Hepatocellular Carcinoma
by: Hao-Chien Hung, et al.
Published: (2021-03-01)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
by: Diederick J. van Doorn, et al.
Published: (2021-12-01)

Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma
by: Mohamed A. Abd El Aziz, et al.
Published: (2020-10-01)

Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
by: Liyun Zheng, et al.
Published: (2021-01-01)

Sorafenib in the treatment of advanced hepatocellular carcinoma
by: Mousa Ali
Published: (2008-01-01)

Sorafenib for the treatment of advanced hepatocellular carcinoma
by: M Connock, et al.
Published: (2010-05-01)

Overview of Current Progress in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma
by: Xinlun Dai MD, et al.
Published: (2020-08-01)

The safety and efficacy of lenvatinib combined with immune checkpoint inhibitors therapy for advanced hepatocellular carcinoma
by: Yun Wang, et al.
Published: (2020-12-01)

Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
by: Yun Hua Lee, et al.
Published: (2020-09-01)

Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma
by: Cui TM, et al.
Published: (2020-11-01)

Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
by: Vito Longo, et al.
Published: (2019-10-01)

Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
by: Anne Dyhl-Polk, et al.
Published: (2021-06-01)

Immune Checkpoint Inhibitors as Monotherapy or Within a Combinatorial Strategy in Advanced Hepatocellular Carcinoma
by: Michela Guardascione, et al.
Published: (2020-08-01)

Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors
by: Vikki Tang, et al.
Published: (2021-02-01)

Cost effectiveness of sorafenib for advanced hepatocellular carcinoma
by: Jung-Chen Ho, et al.
Published: (2017)

Immune Phenotype and Immune Checkpoint Inhibitors for the Treatment of Human Hepatocellular Carcinoma
by: Naoshi Nishida, et al.
Published: (2020-05-01)

Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma
by: Raphael Mohr, et al.
Published: (2021-03-01)

The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
by: Patrizia Leone, et al.
Published: (2021-05-01)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives
by: Piera Federico, et al.
Published: (2020-10-01)

Increased Liquefactive Necrosis Formation After Transarterial Chemoembolization Combined with Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
by: Wang Y, et al.
Published: (2021-09-01)

Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors
by: Peter L. Stern, et al.
Published: (2021-06-01)

Immune Checkpoint Inhibitors versus VEGF Targeted Therapy as Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective Study
by: Anwaar Saeed, et al.
Published: (2020-08-01)

Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma.
by: Sangheun Lee, et al.
Published: (2013-01-01)

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
by: Do Young Kim
Published: (2017-06-01)

Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.
by: Hitomi Takada, et al.
Published: (2018-01-01)

Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
by: Hsu CH, et al.
Published: (2014-06-01)

Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma
by: Hidenari Nagai, et al.
Published: (2012-01-01)

Are the Patients in the Immune Tolerant Phase of Chronic Hepatitis B far from Hepatocellular Carcinoma or Death?
by: Nae-Yun Heo
Published: (2019-07-01)

Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma
by: Su Jin Lim, et al.
Published: (2020-06-01)

Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma
by: Pei-Chang Lee, et al.
Published: (2020-01-01)

Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib
by: Gregor Michael, et al.
Published: (2009-06-01)

Cancer immunotherapy beyond immune checkpoint inhibitors
by: Julian A. Marin-Acevedo, et al.
Published: (2018-01-01)

Next generation of immune checkpoint inhibitors and beyond
by: Julian A. Marin-Acevedo, et al.
Published: (2021-03-01)

Research advances in transarterial chemoembolization combined with sorafenib in treatment of advanced hepatocellular carcinoma
by: WU Lei, et al.
Published: (2018-04-01)

Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib
by: Imane El Dika, et al.
Published: (2020-10-01)

Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma
by: Yang Zhao, et al.
Published: (2019-05-01)